People · Operator
Named in public records as an officer, director or promoter · active 2011–2020 · Pharmaceuticals, Biotechnology, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AEON Biopharma, Inc. | — | Pharmaceuticals | Series C | $197.1M | $511.8M | 2015 |
| AcuFocus, Inc. | — | Biotechnology | Series C | $167.7M | $981.9M | 2011 |
| Strathspey Crown Holdings, LLC | — | Other | Series C | $99.4M | $18.3M | 2012 |
| Crown Sterling Ltd LLC | — | Other Technology | Series A | $6.2M | $142.3M | 2020 |
| Strathspey Crown LLC | — | Other | Seed | $1.4M | $27.0M | 2012 |
Robert E. Grant at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert E. Grant on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Vikram E. Malik | 2 | 2 |
| Robert Grant | 1 | 12 |
| William J. Link | 1 | 10 |
| Buzz Benson | 1 | 8 |
| Charles Larsen | 1 | 7 |
| James Garvey | 1 | 6 |
| Vikram Malik | 1 | 5 |
| Juliet Tammenoms Bakker | 1 | 5 |
| Simone Blank | 1 | 5 |
| Darren O'Brien | 1 | 4 |
| Jost Fischer | 1 | 4 |
| Ali J. Satvat | 1 | 4 |
| Ryan M. Schwarz | 1 | 3 |
| Alex Wilson | 1 | 3 |
| GREG MADDEN | 1 | 3 |
| Charles M. Warden | 1 | 3 |
| Conrad Wang | 1 | 3 |
| Charles V. Larsen | 1 | 2 |
| Hans S. Keirstead | 1 | 2 |
| James M. Garvey | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.